Last reviewed · How we verify

NCT04525443

Endothelial Function and COVID-19

Completed Last updated 26 February 2021
What this trial tests

trial in COVID-19 in 110 participants. Completed in 11 February 2021.

Timeline
3 June 2020
Primary endpoint
11 November 2020
11 February 2021

Quick facts

Lead sponsorHospital San Carlos, Madrid
StatusCompleted
Study typeOBSERVATIONAL
Enrollment110
Start date3 June 2020
Primary completion11 November 2020
Estimated completion11 February 2021
Sites2 locations across United States, Spain

Conditions studied

Sponsor

Hospital San Carlos, Madrid

Who can join

Eligibility, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to investigate the endothelial vasodilator function in patients with COVID-19

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.
    Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al · · 2021 · cited 102× · PMID 33992686 · DOI 10.1016/j.jinf.2021.05.004
  2. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19.
    Mejia-Renteria H, Travieso A, Sagir A, Martínez-Gómez E, et al · · 2021 · cited 42× · PMID 34706286 · DOI 10.1016/j.ijcard.2021.10.140
  3. Endothelial dysfunction in COVID-19: A potential predictor of long-COVID?
    Seitz A, Ong P. · · 2022 · cited 16× · PMID 34838682 · DOI 10.1016/j.ijcard.2021.11.051

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other Hospital San Carlos, Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04525443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing